Nile tilapia piscidin 2, TP2

General Information


DRACP ID  DRACP02332

Peptide Name   Nile tilapia piscidin 2, TP2

Sequence  GECIWDAIFHGAKHFLHRLVNP

Sequence Length  22

UniProt ID  L0CKQ8 

PubChem CID  Not available

Origin  Oreochromis niloticus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma Low active up to 100 µg/ml MTS assay 24 h 1
RAW 264.7 Mouse leukemia Leukemia Low active up to 100 µg/ml MTS assay 24 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=50 µg/ml; Tilapia erythrocytes: 60% Hemolysis=40 µg/ml

Normal (non-cancerous) Cytotoxicity  TO2: ~10% Killing=80 µg/ml; MRC-5: Low active up to 100 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02332

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C119H174N34O28S

Absent amino acids  MQSTY

Common amino acids  H

Mass  293574

Pl  7.62

Basic residues  5

Acidic residues  2

Hydrophobic residues  10

Net charge  3

Boman Index  -1783

Hydrophobicity  3.18

Aliphatic Index  93.18

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  261.9

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23226256

Title  Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions

Doi 10.1371/journal.pone.0050263

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4197

DRACP is developed by Dr.Zheng's team.